Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $76 |
| Triangulated Fair Value | $60 |
| 12-mo Scenario PWEV | $78 |
| Implied Return | -22% |
| Forward P/E | 16.6x |
| Market Cap | $37B |
| 52-Week Range | $50 – $85 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Spike — Supply Dislocation' (8% weight) — targets $159, +108% vs spot. It needs Gross Margin to surprise to the upside.
The dashboard below is the whole argument on one page: spot ($76) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Crush / Protein Margin Reset' (22%) — targets $28, -64% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
Gross Margin explains 68% of Monte Carlo outcome variance — the single variable that decides which side is right.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.43 vs analyst floor +0.05 → delta +0.38 (n=23 mgmt / 16 Q&A; 49th pctile across the S&P book, z -0.1).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.43 | +0.05 | +0.38 |
| 2025Q4 | +0.21 | +0.06 | +0.14 |
| 2025Q3 | +0.35 | +0.17 | +0.18 |
| 2025Q2 | +0.32 | +0.18 | +0.15 |
News (last 365d, 1000 articles): avg ticker sentiment +0.12 (bullish 17% / bearish 6%)
Scenario Analysis
The tree runs from a structural 'Structural — Crush / Protein Margin Reset' downside ($28) to a 'Spike — Supply Dislocation' bull case ($159); the probability-weighted blend (PWEV $78) is +3% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Crush / Protein Margin Reset | 22% | $28 | -64% |
| Cyclical Margin Trough | 18% | $49 | -36% |
| Base — Mid-Cycle Crush / Protein Margins | 32% | $80 | +4% |
| Upcycle — Tight Margins | 20% | $127 | +66% |
| Spike — Supply Dislocation | 8% | $159 | +108% |
| Probability-Weighted (PWEV) | — | $78 | +3% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Crush / Protein Margin Reset (22%, $28). Structural impairment — crush / protein margin reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 27.51; probability: 0.22.
- Cyclical Margin Trough (18%, $49). Cyclical downturn — ag-processing crush margins / protein cycle + commodity & feed costs weakens for 1–2 years before normalising. Drivers — implied_target: 48.98; probability: 0.18.
- Base — Mid-Cycle Crush / Protein Margins (32%, $80). Mid-cycle — normalised ag-processing crush margins / protein cycle + commodity & feed costs; disciplined capital allocation; steady returns. Drivers — implied_target: 79.52; probability: 0.32.
- Upcycle — Tight Margins (20%, $127). Upside — tight crush / protein margins lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 126.83; probability: 0.2.
- Spike — Supply Dislocation (8%, $159). Upside tail — sustained tight conditions or a structural re-rate on tight crush / protein margins. Drivers — implied_target: 158.63; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $70 | -8% |
| Peer P/E re-rate | multiple | $66 | -13% |
| Peer EV/Revenue re-rate | multiple | $229 | +199% |
| Scenario PWEV | multiple | $78 | +3% |
| DCF (5-year + terminal) | cash flow + terminal × | $40 | -47% |
| Triangulated (weighted) | — | $60 | -22% |
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $70 + scenario PWEV $78, ≈ spot); the weighted blend $60 (-22%) sits below it because the cash-flow DCF ($40) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $70 and 45% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (68% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 9.0%, 14x terminal FCF multiple → $40. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 14.375x) implies $66. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is wide (genuine disagreement — low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Agricultural Products & Protein | $80.6B | 100% | 2% | 2% | 17x | 6% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | ag-processing crush margins / protein cycle + commodity & feed costs |
| net_debt_or_cash_b | -10.07 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.06 |
| div_yield | 0.0273 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | crush / protein margin reset |
| upside | tight crush / protein margins |
Industry Context — Consumer Staples — Ag
This name sits in the Consumer Staples — Ag as a ag_products. ag-processing crush margins / protein cycle + commodity & feed costs Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: ADM (ag_products) · BG (ag_products) · TSN (ag_products)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Crush / Protein Margin Reset | 40% | 40% | |
| Mid-Cycle — Normalised Margins | 32% | 32% | |
| Tight-Margin Upcycle | 28% | 28% |
On the cluster's key downside — Crush / Protein Margin Reset () — this name implies 40% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The staples_ag cycle is the shared macro driver. Driver — ag-processing crush margins / protein cycle + commodity & feed costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $82B | $3B | $5B | $5B | $2B | $2B |
| FY+2 | $84B | $3B | $5B | $5B | $2B | $2B |
| FY+3 | $85B | $3B | $5B | $5B | $2B | $2B |
| FY+4 | $86B | $3B | $5B | $5B | $2B | $2B |
| FY+5 | $86B | $3B | $5B | $5B | $2B | $1B |
| Terminal | — | — | — | — | $2B × 14x | $21B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 6% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 9.0% · Σ PV(FCF) $9B + PV(terminal) $21B = EV $30B; + net cash → equity $19B ÷ diluted shares 0.48B = $40/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $46/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 1% vs WACC 9% → below WACC — the incremental build is value-dilutive.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| BG | 0.45x | 14.53x | 2% | 1% |
| KVUE | 2.886x | 16.47x | 4% | 22% |
| KR | 0.376x | 11.16x | 5% | 3% |
| KMB | 2.535x | 14.22x | 4% | 20% |
| Median | 1.4925000000000002x | 14.375x | — | — |
Peer-median fwd P/E → $66; EV/Rev → $229.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $40 | 41% | $17 |
| Scenario PWEV | $78 | 29% | $23 |
| Monte Carlo median | $70 | 18% | $12 |
| Peer P/E | $66 | 12% | $8 |
| Triangulated | — | 100% | $60 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC ＼ Term× | 9.8x | 11.9x | 14.0x | 16.1x | 18.2x |
|---|---|---|---|---|---|
| 7% | $31 | $38 | $46 | $53 | $60 |
| 8% | $29 | $36 | $43 | $50 | $57 |
| 9% | $27 | $34 | $40 | $47 | $53 |
| 10% | $26 | $32 | $38 | $44 | $50 |
| 11% | $24 | $30 | $36 | $42 | $48 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ ＼ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $-7 | $17 | $40 | $64 | $88 |
| -1.5pp | $-10 | $15 | $40 | $66 | $91 |
| +0.0pp | $-14 | $13 | $40 | $67 | $95 |
| +1.5pp | $-17 | $12 | $40 | $69 | $98 |
| +3.0pp | $-21 | $9 | $40 | $71 | $102 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $-14 | $95 | $108 |
| Terminal × ±15% | $34 | $47 | $13 |
| WACC ±1pp | $38 | $43 | $5 |
| Revenue CAGR ±3pp | $40 | $40 | $0 |
| FCF conversion ±10% | $40 | $40 | $0 |
Company lever — SoP/share vs Agricultural Products & Protein multiple (AI re-rating) (base 17x)
| Multiple | 11.9x | 14.4x | 17.0x | 19.5x | 22.1x |
|---|---|---|---|---|---|
| SoP/share | $1,969 | $2,387 | $2,822 | $3,240 | $3,675 |
Load-Bearing Assumptions
DCF: WACC 9%, terminal multiple 14×, FY+5 revenue $86B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
A miss on Gross Margin drops the case toward the structural target $28.
Fact / Inference / Speculation
- FACT: Spot $76; 52-week range $50–$85; engine rating HOLD; base-case target $78 (+3%).
- INFERENCE: Triangulated FV $60 (-22%). Gross Margin explains 68% of Monte Carlo outcome variance — the single variable that decides which side is right.
- SPECULATION: At current prices the embedded bet is that Gross Margin surprises to the upside — Gross Margin carries 68% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $60 (-22% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin (68% of variance) — a fundamental call. SBC runs —M TTM (disclosed in the appendix).